RaySearch Laboratories AB (publ) (FRA:27R)
17.58
0.00 (0.00%)
At close: Feb 20, 2026
RaySearch Laboratories AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 407.3 | 462.74 | 343.68 | 160.27 | 102.54 |
Cash & Short-Term Investments | 407.3 | 462.74 | 343.68 | 160.27 | 102.54 |
Cash Growth | -11.98% | 34.64% | 114.44% | 56.31% | -39.24% |
Accounts Receivable | 473.9 | 444.78 | 383.73 | 370.57 | 317.36 |
Other Receivables | 67.5 | 23.35 | 30.07 | 27.7 | 40.81 |
Receivables | 541.4 | 468.13 | 413.79 | 398.26 | 358.17 |
Inventory | 22 | 10.62 | 9.32 | 14.09 | 29.99 |
Prepaid Expenses | - | 17.19 | 12.36 | 37.47 | 20.13 |
Other Current Assets | - | 26.07 | 23.29 | 17.83 | 5.55 |
Total Current Assets | 970.7 | 984.75 | 802.45 | 627.92 | 516.37 |
Property, Plant & Equipment | 447.3 | 526.66 | 590.42 | 649.07 | 666.54 |
Other Intangible Assets | 558.7 | 548.17 | 530.46 | 518.66 | 523.11 |
Long-Term Accounts Receivable | - | 20.95 | 22.2 | 54.33 | 10 |
Long-Term Deferred Tax Assets | 8.4 | 3.86 | 5.73 | 25.6 | 28.53 |
Other Long-Term Assets | 6.9 | 6.79 | 1.43 | 0.36 | 0.21 |
Total Assets | 1,992 | 2,091 | 1,953 | 1,876 | 1,745 |
Accounts Payable | 35.4 | 38.76 | 42.09 | 24.03 | 48.77 |
Accrued Expenses | - | 57.45 | 41.72 | 50.71 | 44.9 |
Current Portion of Long-Term Debt | - | - | - | - | 21.27 |
Current Portion of Leases | 77.5 | 77.08 | 97.38 | 81.31 | 49.11 |
Current Income Taxes Payable | - | 42.16 | 5.49 | 4.98 | 3.71 |
Current Unearned Revenue | 355.9 | 454.21 | 461.14 | 460.71 | 341.01 |
Other Current Liabilities | 101.1 | 34.16 | 27.24 | 15.36 | 7.98 |
Total Current Liabilities | 569.9 | 703.82 | 675.05 | 637.1 | 516.75 |
Long-Term Leases | 317.3 | 394.86 | 431.98 | 474.08 | 491.02 |
Long-Term Deferred Tax Liabilities | 118.6 | 114.92 | 109.53 | 106.87 | 107.78 |
Other Long-Term Liabilities | 0.9 | 0.88 | 0.88 | 0.74 | 0.88 |
Total Liabilities | 1,007 | 1,214 | 1,217 | 1,219 | 1,116 |
Common Stock | 985.3 | 17.14 | 17.14 | 17.14 | 17.14 |
Additional Paid-In Capital | - | 1.98 | 1.98 | 1.98 | 1.98 |
Retained Earnings | - | 856.93 | 721.98 | 640.41 | 616.63 |
Comprehensive Income & Other | - | 0.66 | -5.87 | -2.37 | -7.44 |
Shareholders' Equity | 985.3 | 876.71 | 735.23 | 657.16 | 628.31 |
Total Liabilities & Equity | 1,992 | 2,091 | 1,953 | 1,876 | 1,745 |
Total Debt | 394.8 | 471.93 | 529.36 | 555.39 | 561.4 |
Net Cash (Debt) | 12.5 | -9.19 | -185.68 | -395.12 | -458.86 |
Net Cash Per Share | 0.36 | -0.27 | -5.42 | -11.53 | -13.38 |
Filing Date Shares Outstanding | 34.28 | 34.28 | 34.28 | 34.28 | 34.28 |
Total Common Shares Outstanding | 34.28 | 34.28 | 34.28 | 34.28 | 34.28 |
Working Capital | 400.8 | 280.93 | 127.4 | -9.18 | -0.39 |
Book Value Per Share | 28.74 | 25.57 | 21.45 | 19.17 | 18.33 |
Tangible Book Value | 426.6 | 328.54 | 204.78 | 138.49 | 105.2 |
Tangible Book Value Per Share | 12.44 | 9.58 | 5.97 | 4.04 | 3.07 |
Machinery | - | 284.68 | 262.43 | 243.37 | 224.37 |
Order Backlog | 1,528 | 1,813 | 1,864 | 1,940 | 1,363 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.